Cita APA (7a ed.)

Y, P., SK, H., TG, M., T, K., C, D., WK, S., . . . TJ, L. (2012). Retinoblastoma treatment: Impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LHBETATAG retinal tumors. Dove Medical Press.

Cita Chicago Style (17a ed.)

Y, Piña, Houston SK, Murray TG, Koru-Sengul T, Decatur C, Scott WK, Nathanson L, Clarke J, y Lampidis TJ. Retinoblastoma Treatment: Impact of the Glycolytic Inhibitor 2-deoxy-d-glucose on Molecular Genomics Expression in LHBETATAG Retinal Tumors. Dove Medical Press, 2012.

Cita MLA (8a ed.)

Y, Piña, et al. Retinoblastoma Treatment: Impact of the Glycolytic Inhibitor 2-deoxy-d-glucose on Molecular Genomics Expression in LHBETATAG Retinal Tumors. Dove Medical Press, 2012.